Search research articles
Contact Us
Filters
Showing results (421-430 of 437) with videos related to
Page
of 44
Sort By:
Oncogene
|
November 11, 2014
FOXC2 promotes colorectal cancer metastasis by directly targeting MET
Y-M Cui, H-L Jiao, Y-P Ye, et al.
ESMO Open
|
June 21, 2025
Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics-based liquid biopsy assay
Y L Peng, B Yu, T X Huang, et al.
Blood Cancer Journal
|
April 8, 2022
Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3"
K H Begna, X Xu, N Gangat, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|
December 7, 2023
[Application and evaluation of artificial intelligence TPS-assisted cytologic screening system in urine exfoliative cytology]
L Zhu, M L Jin, S R He, et al.
Leukemia
|
January 12, 2017
A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome
A D Kelly, H Kroeger, J Yamazaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 6, 2024
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040
I Melero, T Yau, Y-K Kang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 8, 2025
Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular Carcinoma
Xiyan Xiang, Kirti Shetty, Herbert Yu, et al.
Genes & Cancer
|
February 7, 2024
Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis
Xiyan Xiang, Krishanu Bhowmick, Kirti Shetty, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
March 28, 2024
[Comparison of the efficacy of different surgical strategies in the treatment of patients with initially resectable gastric cancer liver metastases]
L Li, Y H Gao, L Zang, et al.
ESMO Open
|
January 11, 2025
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study
G Ku, G M Haag, H Park, et al.
Page
of 44
Search research articles
Search
Showing results (421-430 of 437) with videos related to
Sort By:
Page
of 44
Oncogene
|
November 11, 2014
FOXC2 promotes colorectal cancer metastasis by directly targeting MET
Y-M Cui, H-L Jiao, Y-P Ye, et al.
ESMO Open
|
June 21, 2025
Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics-based liquid biopsy assay
Y L Peng, B Yu, T X Huang, et al.
Blood Cancer Journal
|
April 8, 2022
Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3"
K H Begna, X Xu, N Gangat, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|
December 7, 2023
[Application and evaluation of artificial intelligence TPS-assisted cytologic screening system in urine exfoliative cytology]
L Zhu, M L Jin, S R He, et al.
Leukemia
|
January 12, 2017
A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome
A D Kelly, H Kroeger, J Yamazaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 6, 2024
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040
I Melero, T Yau, Y-K Kang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 8, 2025
Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular Carcinoma
Xiyan Xiang, Kirti Shetty, Herbert Yu, et al.
Genes & Cancer
|
February 7, 2024
Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis
Xiyan Xiang, Krishanu Bhowmick, Kirti Shetty, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
March 28, 2024
[Comparison of the efficacy of different surgical strategies in the treatment of patients with initially resectable gastric cancer liver metastases]
L Li, Y H Gao, L Zang, et al.
ESMO Open
|
January 11, 2025
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study
G Ku, G M Haag, H Park, et al.
Page
of 44